Eupraxia Pharmaceuticals (EPRX) Payables (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Payables of $8.39 million for Q2 2026, up 224.8% from $2.58 million a year earlier and up 17.2% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Payables (2022 - 2026) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals' Payables came in at $5.55 million, up 83.1% from FY2024.
- Annual Payables shows a three-year compound annual growth rate of 23.7% (FY2022 to FY2025).
- In prior years, Eupraxia Pharmaceuticals' Payables was $3.03 million in FY2024 (-22.7%), $3.92 million in FY2023 (+33.9%) and $2.93 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Payables in data going back to Q4 2022.
- On a year-over-year basis, Payables has increased in each of the last five quarters, with growth averaging 80.9% over the last seven quarters.
- The strongest year-over-year quarter for Payables in the past five years was Q1 2026, with growth of 233.4%; the weakest was Q1 2025, with a decline of 45.9%.
- According to Business Quant data, Payables for the three prior quarters was $7.16 million (Q1 2026), $5.55 million (Q4 2025) and $3.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 10.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.10 Mn |
| Jun 30, 2026 | 8.39 Mn |
| Mar 31, 2026 | 7.16 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 3.97 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Dec 31, 2022 | 2.93 Mn |
API Access
Eupraxia Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();